Affiliation:
1. Qinghai Provincial Key Laboratory of Tibetan Medicine Research, Northwest Institute of Plateau Biology, Chinese Academy of Sciences, Xining 810001, China
2. University of Chinese Academy of Sciences, Beijing 100049, China
3. Key Laboratory of Tibetan Medicine Research, Chinese Academy of Sciences, Xining 810001, China
Abstract
Rheumatoid arthritis (RA) is a chronic autoimmune disease with a global prevalence of approximately 0.46%, causing significant impairments in patients’ quality of life and an economic burden. Saussurea involucrata (SI) has long been used in traditional medicine to treat RA, but its underlying mechanism remains unclear. This study utilized network pharmacology and molecular docking to explore the potential pharmacological effects of bioactive compounds in SI on RA. A total of 27 active compounds were identified, along with 665 corresponding targets. Additionally, 593 disease-related targets were obtained from multiple databases, with 119 common targets shared with SI. The high-ranking targets mainly belong to the MAPK family and NF-κB pathway, including MAPK14, MAPK1, RELA, TNF, and MAPK8, all of which are associated with inflammation and joint destruction in RA. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis revealed significant pathways related to IL-17 signaling, Th17 cell differentiation, and osteoclast differentiation. Molecular docking and dynamic simulations demonstrated strong interactions between several flavonoids and RA-related targets. Xuelianlactone, Involucratin, and Flazin exhibit outstanding binding efficacy with targets such as MAPK1, MAPK8, and TNF. These findings provide valuable insights into the therapeutic potential of SI for RA and offer directions for further drug development.
Funder
Qinghai Provincial Natural Science Foundation General Project
Qinghai Provincial Key Laboratory of Tibetan Medicine Research Innovation Platform Development Special Project
Subject
Food Science,Nutrition and Dietetics
Reference67 articles.
1. The global prevalence of rheumatoid arthritis: A meta-analysis based on a systematic review;Almutairi;Rheumatol. Int.,2021
2. Disease burden and quality of life of rheumatoid arthritis in China: A systematic review;Zeng;Chin. J. Evid. Based Med.,2013
3. Zeng, X., Tian, X., and Li, M. (2021). China Rheumatoid Arthritis Development Report 2020, Liaoning Science and Technology Press.
4. 2018 Chinese guidelines for the diagnosis and treatment of rheumatoid arthritis;Tian;Rheumatol. Immunol. Res.,2021
5. van Vollenhoven, R.F. (2009). Sex differences in rheumatoid arthritis: More than meets the eye. BMC Med., 7.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献